More clinical performance data for Actim ELISA SARS-CoV-2 IgG

Comparison to PCR

An evaluation study of over 600 serum samples confirmed the excellent performance of the upcoming Actim ELISA SARS-CoV-2 IgG test:

Sensitivity Specificity PPV NPV Accuracy
96% 99% 90% 99% 98%

Overall performance data of serum samples collected ≥ 7 days after the positive PCR results.

A head-to-head comparison

Actim ELISA SARS-CoV-2 IgG test has the best sensitivity compared to competitors:

Method Sensitivity
Actim ELISA SARS-CoV-2 IgG S1 96%
ELISA IgG, Competitor A 70%
ELISA IgG, Competitor B 73%
ELISA IgG, Competitor C 80%

Clinical specificity

Actim ELISA SARS-CoV-2 IgG kit was evaluated for cross-reactivity with other viruses. A negative test result was obtained with all samples:

  • Adenovirus IgG
  • Cytomegalie Virus (CMV) IgG
  • Herpes Simplex 1+2 IgG
  • Influenzaviruses type A IgG
  • Influenzaviruses type B IgG
  • Mumps Virus (Parotitis) IgG
  • Mycoplasma pneumoniae IgG
  • Parainfluenza 1/2/3 IgG
  • Parvovirus B19 IgG
  • Respiratory Cyncytial Virus IgG
  • Varicella Zoster Virus IgG
  • Anti-Epstein-Barr-Virus-Capsid-Antigen IgG
  • Anti-Enteroviruses IgG
  • Anti-Measles Virus IgG
  • Anti-Hanta-Virus Pool 1 ”Eurasia” IgG
  • Haemophilus influenzae B IgG